Key result
MPIO-αVCAM-1 enhanced MRI non-invasively maps silent endothelial activation in mouse models of cardiovascular risk.
Why the study?
Suitable methods to measure endothelial activation in vivo are lacking despite its key role in cardiovascular diseases.
Does molecular magnetic resonance imaging allow non-invasive detection of silent endothelial activation in mice models of cardiovascular risk?
Does molecular magnetic resonance imaging allow non-invasive detection of silent endothelial activation in mice models of cardiovascular risk?
A novel molecular MRI method successfully detects silent endothelial activation in vivo in preclinical models, offering a potential tool for early identification of cardiovascular risk.
Hypothesis-generating for molecular MRI of endothelial activation; human validation required before clinical translation.
Endothelial activation is a hallmark of cardiovascular diseases, acting either as a cause or a consequence of organ injury. To date, we lack suitable methods to measure endothelial activation in vivo. In the present study, we developed a magnetic resonance imaging (MRI) method allowing non-invasive endothelial activation mapping in the vasculature of the main organs affected during cardiovascular diseases. In clinically relevant contexts in mice (including systemic inflammation, acute and chronic kidney diseases, diabetes mellitus and normal aging), we provided evidence that this method allows detecting endothelial activation before any clinical manifestation of organ failure in the brain, kidney and heart with an exceptional sensitivity. In particular, we demonstrated that diabetes mellitus induces chronic endothelial cells activation in the kidney and heart. Moreover, aged mice presented activated endothelial cells in the kidneys and the cerebrovasculature. Interestingly, depending on the underlying condition, the temporospatial patterns of endothelial activation in the vascular beds of the cardiovascular system were different. These results demonstrate the feasibility of detecting silent endothelial activation occurring in conditions associated with high cardiovascular risk using molecular MRI.
No takes yet. Share an insight, caveat, or question.
Bellière et al. (2015) studied Endothelial activation in cardiovascular diseases. MPIO-αVCAM-1 vs. MPIO-IgG or saline was evaluated on Volume of MPIOs-induced signal void divided by the volume of the structure of interest. MPIO-αVCAM-1 enhanced MRI allowed non-invasive, highly sensitive mapping of silent endothelial activation in the vasculature of the brain, kidney, and heart in mouse models of cardiovascular risk factors.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: